Improving Outcomes in Infants of HIV-Infected Women in Haiti
Author Information
Author(s): Noel Francine, Mehta Sapna, Zhu Yuwei, Rouzier Patricia De Matteis, Marcelin Abdias, Shi Jian R., Nolte Claudine, Severe Linda, Deschamps Marie Marcelle, Fitzgerald Daniel W., Johnson Warren D., Wright Peter F., Pape Jean W.
Primary Institution: Les Centres GHESKIO, Port-au-Prince, Haiti
Hypothesis
Can a comprehensive PMTCT program reduce mother-to-child transmission of HIV and improve infant survival in a resource-limited setting?
Conclusion
The study demonstrates significant success in reducing mother-to-child HIV transmission and infant mortality in Haiti through a comprehensive PMTCT program.
Supporting Evidence
- Transmission rates fell from 27% to 10% after the introduction of HAART.
- Infant mortality rate decreased significantly from 0.23 to 0.12 per year after HAART was introduced.
- Only 1.9% of infants born to mothers on HAART were HIV-positive.
Takeaway
This study shows that giving HIV-infected mothers the right medicine can help keep their babies from getting HIV and help them live longer.
Methodology
Data from 551 infants born to HIV-infected mothers were analyzed, focusing on transmission rates and mortality before and after the introduction of HAART.
Potential Biases
Self-reporting of adherence to therapy may introduce bias.
Limitations
The study was not randomized, and only 421 mother-infant pairs had complete data for all risk factors.
Participant Demographics
Median maternal age was 27 years, with 20% of infants having low birth weight.
Statistical Information
P-Value
p<0.0001
Confidence Interval
0.08–0.16
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website